The Limited Times

Now you can see non-English news...

Vaccines: producing billions of doses remains a titanic challenge

2021-03-12T15:52:36.884Z


After developing their precious serums in record time, the laboratories face another major challenge.


In a few days, the first vaccines will be produced on French territory.

The subcontractors Delpharm and Recipharm are in the starting blocks.

Almost simultaneously, the production lines of their factories in Saint-Rémy-sur-Avre (Eure-et-Loir) and Monts (Indre-et-Loire) will start up in order to produce the vaccines of Pfizer / BioNTech and of Moderna, and the first deliveries of “made in France” doses should take place in April.

Read also:

Contagiousness, mortality, resistance to vaccines: are the different variants of Covid-19 really more dangerous?

France is not alone in participating in the general mobilization.

Vaccine factories around the world are at war.

Because after having developed their precious serums in record time, the labs are facing another major challenge: to produce and distribute several billion doses to the whole world in just a few months.

A titanic task.

Pfizer / BioNTech has promised 2 billion doses in 2021 (against 1.3 billion initially).

Moderna has pledged to deliver up to 1 billion.

AstraZeneca,

This article is for subscribers only.

You have 78% left to discover.

Subscribe: 1 € the first month

Can be canceled at any time

I ENJOY IT

Already subscribed?

Log in

Source: lefigaro

All tech articles on 2021-03-12

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.